CIK 0001819133
- Non-accelerated filer
- Smaller reporting company
Tango Therapeutics, Inc.
Sign in to watch- Ticker
- TNGX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 857-320-4900
- Business address
- 201 BROOKLINE AVENUE, SUITE 901, BOSTON, MA, 02215
- Former names
- BCTG Acquisition Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,938,345
- in 7 filings, $1.9M under 10b5-1 plans
Net −$1,938,345. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-08 | Peters Malte President & CEO | Grant or award | +350,000 | 367,500 | ||
| 2026-01-08 | Peters Malte President & CEO | Grant or award · Stock Option (Right to Buy) | +1,650,000 | 1,650,000 | ||
| 2025-11-03 | Peters Malte Director | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2025-06-05 | Peters Malte Director | Grant or award | +6,250 | 17,500 | ||
| 2025-06-05 | Peters Malte Director | Grant or award · Stock Option (Right to Buy) | +37,500 | 37,500 | ||
| 2024-06-05 | Peters Malte Director | Grant or award | +6,250 | 11,250 | ||
| 2024-06-05 | Peters Malte Director | Grant or award · Stock Option (Right to Buy) | +37,500 | 37,500 | ||
| 2023-06-06 | Peters Malte Director | Grant or award | +5,000 | 5,000 | ||
| 2023-06-06 | Peters Malte Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2022-06-08 | Peters Malte Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 |
Page 1 of 1 · 10 trades